McClain to Hold Hearing with FDA’s Food Safety Director on Infant Formula Crisis
WASHINGTON—Health Care and Financial Services Subcommittee Chairwoman Lisa McClain (R-Mich.) today announced a hearing titled “FDA Oversight Part II: Responsibility for the Infant Formula Shortage.” The hearing will continue the Oversight Committee’s investigation into the 2022 nationwide infant formula crisis and examine the U.S. Food and Drug Administration’s (FDA) response.
“The Oversight Committee is investigating the decisions that led our nation into an infant formula crisis, ensuring our agencies are held accountable, and finding solutions to better protect American families in the future. At our last hearing on this subject, a former FDA official confirmed that the FDA’s internal failures created and exacerbated the formula crisis. We still have many unanswered questions. Why was the FDA unprepared for this crisis? Why did they fail to conduct adequate inspections of formula facilities? And why did they fail to heed whistleblower warnings? We will discuss these topics and more with Dr. Mayne, who was at the center of the FDA prior to and during the formula crisis and is a key witness in this investigation,” said Chairwoman McClain.
WHAT: Hearing titled “FDA Oversight Part II: Responsibility for the Infant Formula Shortage”
DATE: May 11, 2023
TIME: 2:00 PM ET
LOCATION: 2154 Rayburn House Office Building
WITNESS: Dr. Susan Mayne, Director of the Center for Food Safety and Applied Nutrition, FDA
Background:
Following requests to appear before the Subcommittee on Health Care and Financial Services, Chairwoman Lisa McClain (R-Mich.) requested Dr. Mayne appear for a transcribed interview. The transcribed interview request prompted Dr. Mayne to finally arrange availability for testimony at a public hearing. The Oversight Committee held its first hearing on the infant formula crisis, “FDA Oversight Part 1: The Infant Formula Shortage” in March 2023.
READ MORE:
FDA’s Food Safety Director Agrees to Testify on Infant Formula Crisis
Hearing Wrap Up: Former FDA Official: Infant Formula Crisis Was “A Preventable Tragedy”
The hearing will be open to the public and press and will be livestreamed online at https://oversight.house.gov/.